The Opportunity Fund will support novel functional follow-up on candidate variants that the investigators in the Consortium have identified but are not able to confirm as causal. It is expected that these awards will be issued starting in the second year of the GREGoR Consortium (beginning April 2022) and will each last one year. The process for announcing and making these awards is under development. Please keep an eye on this web page for more information.